Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1248 results about "Immunity response" patented technology

The Immune response is the body's response caused by its immune system being activated by antigens. The immune response can include immunity to pathogenic microorganisms and its products, allergies, graft rejections, as well as autoimmunity to self-antigens.

Federated Distributed Computational Graph Platform for Oncological Therapy and Biological Systems Analysis

A federated distributed computational system enables secure biological data analysis and genomic medicine with enhanced oncological therapy capabilities. The system implements patient-specific tumor-on-a-chip analysis through microfluidic control systems and cellular heterogeneity preservation, while integrating fluorescence-enhanced diagnostics using CRISPR-LNP targeting and robotic surgical navigation. The architecture coordinates spatiotemporal analysis of gene therapy delivery through molecular imaging and immune response tracking, and implements bridge RNA integration with multi-target synchronization. Treatment selection is optimized through multi-criteria scoring and patient-specific simulation modeling. Each federated node contains a local processing unit for biological data analysis, privacy preservation protocols, and a hierarchical knowledge graph structure. The system implements cross-species genetic analysis, environmental response modeling, and multi-scale tensor-based data integration, enabling research institutions to collaborate on complex, large-scale biological analyses while maintaining strict data privacy controls.
Owner:QOMPLX INC

Imidazo pyrimidine compounds for the treatment of cancer

PCT designated stage expiredWO2025026903A1Organic chemistryAntineoplastic agentsDiseaseKRAS
The present invention covers imidazo pyrimidine compounds of general formula (I), in which R1, R2, R3, R4 and Z are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of neoplastic disorders, respectively cancer or conditions with dysregulated immune responses or other disorders associated with aberrant KRAS signaling, as a sole agent or in combination with other active ingredients.
Owner:BAYER AG

Recombinant herpes zoster vaccine as well as preparation method and application thereof

ActiveCN119386170Ahigh titerstrong immune responseAntibody mimetics/scaffoldsViral antigen ingredientsHerpes zoster virusHerpes Zoster Vaccine
The invention discloses a recombinant herpes zoster vaccine as well as a preparation method and application thereof, and particularly relates to the technical field of biological medicines. The recombinant herpes zoster vaccine comprises a recombinant herpes zoster vaccine fusion protein purified product HN101 and a liposome mixture HA201, and the recombinant herpes zoster fusion protein gE-gD is constructed by recombining reconstructed gE protein and reconstructed gD protein. The gE-gD recombinant herpes zoster fusion protein is obtained by reconstructing gE protein of varicella-herpes zoster virus and gD protein of HSV through a gene recombination technology and then recombining the gE protein and the gD protein. After the gE-gD recombinant herpes zoster fusion protein is combined with a liposome mixture HA201, stronger immune response can be induced, the antibody titer and cellular immunity are improved, the vaccine effect is enhanced, and meanwhile, the potential infection risk is avoided.
Owner:JIANGSU WALVAX BIOTECHNOLOGY CO LTD

Macrobrachium rosenbergii disease-resistant immune related gene Lamp1 and application thereof

InactiveCN119061020ASolve technical issues that make monitoring of viral diseases difficultImplement screening and cultivationBacteriaPeptide/protein ingredientsDiseaseNucleotide
The invention discloses a macrobrachium rosenbergii disease-resistant immune related gene Lamp1 and application thereof. The nucleotide sequence of the macrobrachium rosenbergii disease-resistant immune related gene Lamp1 is shown as SEQ ID NO. 1. The invention provides the macrobrachium rosenbergii disease-resistant immune related gene Lamp1 which can respond to DIV1 and has high expression characteristic in the immune response of macrobrachium rosenbergii infected with DIV1, and the gene plays an important role in the immune defense process of resisting DIV1 infection of macrobrachium rosenbergii. After healthy macrobrachium rosenbergii is infected with DIV1, the expression level of the macrobrachium rosenbergii disease-resistant immunity related gene Lamp1 is remarkably increased, so that the macrobrachium rosenbergii disease-resistant immunity related gene Lamp1 can be used for detecting whether the macrobrachium rosenbergii is infected with DIV1 or not, the technical problem that the viral diseases of the macrobrachium rosenbergii are difficult to monitor is solved, and the application prospect is wide. The method can be used for identifying the anti-DIV1 level of macrobrachium rosenbergii individuals, so that screening and breeding of macrobrachium rosenbergii DIV1-resistant varieties are realized.
Owner:YANGZHOU UNIV

Molecules for controlling immune response

The present disclosure provides inter alia, molecules comprising a binding domain that binds specifically to a target antibody and at least one modified Fc domain. The present disclosure also provides methods and compositions that allow for selective depletion and / or neutralization of pathogenic antibodies.
Owner:MERIDA BIOSCIENCES INC

Denova synthetic 5' untranslated regions (UTR)

The invention relates to a polynucleotide, comprising at least one 5' untranslated region (5'UTR) and at least one open reading frame (ORF). It has improvd mRNA stability, protein expression and can induce improved immune response.
Owner:INNOVAC THERAPEUTICS HK LTD

Preparation method of bovine rotavirus monoclonal antibody and bovine rotavirus quantum dot immunochromatography test strip

PendingCN119841939AImmunoglobulins against virusesBiological testingBovine rotavirusPrimary Veterinarian
The invention discloses a bovine rotavirus monoclonal antibody and a preparation method of a bovine rotavirus quantum dot immunochromatography test strip, and belongs to the technical field of bovine rotavirus monoclonal antibodies. According to the invention, a hybridoma cell strain BRV 3G9 is utilized, and a monoclonal antibody is prepared by adopting an ascites method; the BRV 3G9 is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC No.46138. The BRV 3G9 is named as BRV 3G9. According to the present invention, the concentrated live virus immunized mouse is adopted to prepare the monoclonal antibody with strong immunoreaction, and the BRV quantum dot immunochromatography test strip is researched and developed on the basis of the monoclonal antibody, and has advantages of convenient use, high efficiency, high sensitivity, strong specificity and the like, and can achieve the rapid clinical differential diagnosis of calf diarrhea pathogens, the problem that grassroots veterinarians lack a clinical rapid detection technology is solved, the diagnosis and treatment level and the prevention and treatment effect are improved, and technical guarantee is provided for efficiently preventing and treating calf diarrhea and guaranteeing calf health.
Owner:HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY +1

Recombinant novel coronavirus Omicron variant RBD trimer antigen, immunogenic composition containing same and application of recombinant novel coronavirus Omicron variant RBD trimer antigen

The invention relates to a novel coronavirus recombinant chimeric antigen, a related product thereof, a preparation method and application of the novel coronavirus recombinant chimeric antigen in preparation of a novel coronavirus vaccine. The recombinant chimeric antigen is a recombinant new coronavirus Omicron variant RBD trimer antigen, various types of vaccines based on the recombinant chimeric antigen can induce strong immune response aiming at various subtype variants (including BA.1, BA.2, BA.5, XBB, EG.5, BA.2. 86, JN.1, KP.2 and the like) of the new coronavirus Omicron, and particularly, compared with a protein vaccine of the recombinant chimeric antigen, the recombinant chimeric antigen can induce strong immune response. The mRNA vaccine based on the recombinant chimeric antigen can induce an organism to generate obviously higher RBD specific binding antibody level and neutralizing antibody level, so that the mRNA vaccine can be used as a candidate of a new generation of new coronavirus vaccines, and has potential clinical application value and prospect.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Cattle spleen active polypeptide capable of enhancing immunity and preparation method and functional product thereof

The invention relates to the technical field of deep processing of cattle spleen, in particular to cattle spleen active polypeptide capable of enhancing immunity and a preparation method and a functional product thereof. The preparation method comprises the following steps: mincing cattle spleen, adding water, uniformly mixing, heating and curing; adding bacillus licheniformis alkaline protease to carry out hydrolysis for the first time; adding papain and bacillus subtilis flavourzyme into the first hydrolysate to carry out hydrolysis for the second time; and performing enzyme deactivation on the second hydrolysate, and sequentially performing fishy smell removal, decolorization, filtration, concentration and drying treatment to obtain the cattle spleen polypeptide. The cattle spleen polypeptide prepared by the invention can obviously enhance the immune response of a body and play a role in enhancing immunity, can be applied to a functional product for enhancing immunity as a functional factor, has the advantages of low equipment requirement, simple process, easiness in operation, high extraction efficiency and the like, is suitable for industrial production, and has a wide application prospect. The scheme of the invention has good application and economic prospects.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Ackermania muciniphila YG2645 with function of regulating intestinal-immune-metabolic axis and application of Ackermania muciniphila YG2645

The invention relates to the field of microorganisms, in particular to Akkermansia muciniphila YG2645 with an intestinal tract-immune-metabolic axis regulating function, an inactivated thallus, an extract, a culture, a culture supernatant, a fermentation product and / or a fermentation supernatant of the Akkermansia muciniphila YG2645, a composition containing the Akkermansia muciniphila YG2645 and a preparation method of the composition containing the Akkermansia muciniphila YG2645 and the composition containing the Akkermansia muciniphila YG2645 and the composition containing the composition. The invention also relates to application of the compound in preparation of products for preventing and / or treating inflammatory diseases. The Akkermansia muciniphila YG2645 and related products of the Akkermansia muciniphila YG2645 have the functions of regulating and controlling immune response, regulating and controlling metabolism, regulating intestinal flora and the like, and the Akkermansia muciniphila YG2645 and the related products of the Akkermansia muciniphila YG2645 have remarkable application value and market potential.
Owner:BEIJING YUJING PHARM CO LTD

Small secretory peptide and application thereof in plant immune excitation

The invention belongs to the technical field of plant immunity, and particularly relates to a small secretory peptide and application thereof in plant immune excitation. The small secretory peptide SlSolP12 (SEQ ID NO.1) is found in solanaceae plants for the first time, and when the small secretory peptide SlSolP12 (SEQ ID NO.1) is used alone or in combination with other small secretory peptides, the immune response of the plants can be activated, so that the systematic resistance of the plants to pathogens is triggered. Therefore, the SlSolP12 provided by the invention can be used as a wide and effective plant immunity excitant, and has a good application prospect.
Owner:SICHUAN AGRI UNIV +1

Canine atopic dermatitis animal model of and use thereof

PCT designated stage expiredWO2025116616A1Peptide/protein ingredientsPharmaceutical delivery mechanismEpicutaneous sensitizationClinical research
The present invention relates to a method for producing a canine atopic dermatitis animal model, a canine atopic dermatitis animal model produced thereby, and a use thereof. According to the present invention, a canine atopic dermatitis animal model is produced by skin stimulation on a dog through epicutaneous sensitization with ovalbumin at a concentration of 1 to 5 mg / ml once daily for 1 to 2 weeks and then with ovalbumin at a concentration of 1 to 5 mg / ml once daily for 2 to 8 weeks. The resulting animal model exhibits clinical symptoms of atopic dermatitis, changes in relevant factors such as increased expression levels of IgE and CCL17, and elevated expression levels of Th2-related cytokines IL-4, IL-31, and IL-13. Therefore, this invention enables the establishment of a standardized animal model for symptoms and Th2 immune responses appearing upon the onset of atopic dermatitis, and the model can be used in clinical studies for screening candidate agents for the prevention, alleviation, or treatment of atopic dermatitis.
Owner:KOREA RES INST OF CHEM TECH

Recognition method of key mitochondrial autophagy and ferroptosis genes in sepsis-induced ARDS and immunoregulation mechanism thereof

The invention discloses a method for identifying key mitochondrial autophagy and ferroptosis genes in sepsis-induced ARDS and an immunoregulation mechanism of the key mitochondrial autophagy and ferroptosis genes. The method comprises the following steps: screening differential expression genes DEGs related to the sepsis-induced ARDS from a GEO gene expression database; and screening the DEGs by using LASSO and SVM + RFE, and identifying 12 key DEGs. The diagnostic potential of the genes in sepsis-induced ARDS is verified through an ROC curve, and the effect of the genes in immune response is disclosed through gene enrichment analysis and immune infiltration analysis. According to the invention, a key gene FTH1 is identified, a miRNA gene [miR-224-5p] targeting the FTH1 and a pathologic process in which the miRNA gene [miR-224-5p] participates in regulation and control of sepsis-induced ARDS are found, and a close relationship between the FTH1 and E3 ubiquitin ligase SMURF1 is found.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIV +1

Application of cembratrienol in preparation of medicine for preventing and / or treating psoriasis

The invention relates to application of cembratrienol in preparation of a medicine for preventing and / or treating psoriasis, and belongs to the technical field of biological medicine. The invention provides an application of cembratrienol in preparation of a medicine for preventing / or treating psoriasis. Researches find that cembratrienol can significantly inhibit secretion of inflammatory factors in a psoriasis-like cell model induced by M5; moreover, research finds that cembratrienol can significantly improve the skin lesion condition of an imiquimod-induced psoriasis mouse model, improve the weight loss degree of the psoriasis mouse model, relieve the pruritus condition of the psoriasis mouse model, improve the skin inflammation of the psoriasis mouse model, repair the skin barrier of the psoriasis mouse model, and improve the curative effect of the psoriasis mouse model. The body immune response of the psoriasis mouse model is reduced. Therefore, cembratrienol has a great application prospect in preparation of the medicine for preventing / treating psoriasis.
Owner:BEIJING LIFE SCIENCE ACADEMY CO LTD

Intelligent monitoring and management method and system for postoperative care of tumor patient

The invention discloses an intelligent monitoring and management method and system for postoperative care of tumor patients, and relates to the field of data analysis, and the main scheme is as follows: calculating a postoperative care state value # imgabs5 # according to a stability index # imgabs0 #, an equilibrium index # imgabs1 #, a wound inflammation immune response index # imgabs2 #, a pain tolerance and psychological toughness association index # imgabs3 # and a body temperature and immune response index # imgabs4 #; the problem that evaluation indexes are not comprehensive enough, are limited to basic vital sign data and meanwhile ignore relevance among different types of data, so that evaluation accuracy is reduced is solved, the body state of the user is judged according to the nursing state value # imgabs6 # and the nursing state threshold set, the body state of the patient can be accurately judged, and the evaluation accuracy is improved. And the efficiency and the pertinence of nursing work can be improved.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Application of breast milk-derived plant lactobacillus to improvement of allergic diseases and regulation of intestinal flora

The invention discloses an application of a breast milk-derived plant lactobacillus in improving allergic diseases and regulating intestinal flora, and belongs to the technical field of microorganisms. The plant lactobacillus GDMCC No: 63060 disclosed by the invention is obtained by being separated from breast milk. The strain provided by the invention has excellent gastrointestinal fluid tolerance, mucin adhesion and antibiotic sensitivity, can inhibit various pathogenic bacteria, can generate indole derivatives, effectively inhibits eczema mouse dermatitis symptoms, inhibits Th2 type immunoreaction hyperpolarization, and induces regulatory T cells. Therefore, the lactobacillus plantarum FN029 has a huge application prospect in preparation of products for inhibiting enteropathogenic bacteria, improving allergic diseases, regulating intestinal flora or promoting digestion function.
Owner:SHANGPIN HEALTH TECH (QINGDAO) CO LTD

A strain of Lactobacillus paracasei that simultaneously activates immune regulatory and antioxidant pathways to alleviate vaginitis

The present invention discloses a strain of Lactobacillus paracasei that simultaneously activates immune regulation and antioxidant pathways to alleviate vaginitis, belonging to the field of microbial technology. The present invention screened and obtained a strain of Lactobacillus paracasei CCFM1316, which has the effect of repairing related symptoms such as immune disorders and oxidative damage caused by vaginitis, specifically embodied in: reducing cellular NF-κB mRNA expression and cell supernatant IL-1β content, improving mouse vaginal immune response, enhancing mouse vaginal antioxidant capacity, improving mouse vaginal pathological manifestations and reducing pathogenic bacteria load. It reduces the mouse vaginal Gardnerella load and improves mouse vaginal pathological manifestations; therefore, Lactobacillus paracasei CCFM1316 has great application prospects in products that improve and repair immune disorders and oxidative damage problems caused by vaginitis.
Owner:JIANGNAN UNIV

MsCYP1 gene of sorghum aphid as well as encoding protein, dsRNA (double-stranded ribonucleic acid) and application of MsCYP1 gene

The invention discloses a sorghum aphid MsCYP1 gene as well as an encoding protein, dsRNA (double-stranded ribonucleic acid) and application thereof, and aims to solve the technical problem that a key gene is lacked when an RNA (ribonucleic acid) interference technology is used for biological prevention and control of sorghum aphids at present. According to the application, the sorghum aphid protein MsCYP1 capable of being secreted into sorghum cells is screened, and the protein and the coding gene thereof can inhibit the content of hydrogen peroxide in sorghum and the immune response of the sorghum. Meanwhile, according to the cDNA sequence of the MsCYP1 gene of the sorghum aphid, dsRNA for the gene is designed, the dsRNA is introduced into the body of the sorghum aphid in an artificial feeding mode, it is found that the dsRNA can remarkably inhibit the MsCYP1 gene of the sorghum aphid, then the honeydew secretion amount and the reproduction rate of the sorghum aphid are affected, the MsCYP1 gene can serve as an RNAi target gene to be used for aphid prevention and control, pesticide use is reduced, and the application prospect is good. The ecological balance is maintained.
Owner:HENAN AGRICULTURAL UNIVERSITY

Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein

Methods of preparing influenza viruses having altered immunodominant epitopes in HA, e.g., having one or more residues in one or more of antigenic sites A-E in HA altered, and viral vectors, e.g., influenza virus VLPs or non-influenza viruses or VLPs thereof expressing or having influenza HAs with altered immunogenicity as a result of altered immunodominant epitopes therein are provided.
Owner:WISCONSIN ALUMNI RES FOUND

Application of OsDOF3 protein or coding gene thereof in improving broad-spectrum disease resistance of rice and regulating agronomic traits

The invention belongs to the field of molecular biology, and particularly relates to application of OsDOF3 protein or a coding gene thereof to improvement of rice broad-spectrum disease resistance and regulation of agronomic traits. According to the application, an OsDOF3 knockout mutant and an overexpression transgenic line are constructed under the background of susceptible rice, resistance phenotype analysis is performed by inoculating various pathogenic bacteria (including pyricularia oryzae, rhizoctonia solani and bacterial blight), and it is proved that OsDOF3 participates in regulation and control of an immunoreaction pathway of rice to fungal diseases (rice blast and sheath blight) and bacterial diseases (bacterial blight). Meanwhile, the application also finds that after a strong promoter ubi is adopted for driving, an overexpression material of the OsDOF3 is shorter than that of a wild plant, and the OsDOF3 influences normal growth and development of rice while stimulating plant immune response. The invention provides important gene resources and molecular theoretical basis for developing a new variety of broad-spectrum disease-resistant rice.
Owner:FUDAN UNIVERSITY

Controlled lesion and immune response to pulsed electric field therapy

Treatment of damaged, diseased, abnormal, obstructive, cancerous or undesired tissue (e.g. a tumor, a benign tumor, a malignant tumor, a cyst, or an area of diseased tissue, etc) is provided by delivering specialized pulsed electric field (PEF) energy to target tissue areas in a specific dose so as to obtain a superior outcome. The PEF energy and delivery has been optimized to provide advanced treatment of target tissue areas, including destruction of undesired tissue and generation of improved inflammatory and immune responses. These various types of treatment are controlled by a variety of factors including the electrode geometry, the dose of PEF energy delivered, the time the energy is delivered over, and the waveform of the PEF energy itself. The PEF energy is delivered in the form a dose which is considered to be one application of the specialized energy. Each dose creates a lesion in the target tissue area.
Owner:GALVANIZE THERAPEUTICS INC

Application of ackermann muciniphile or external vesicles thereof in preparation of drugs for treating schistosomiasis

The invention belongs to the technical field of biological medicines, and relates to application of Ackermann muciniphile or its external vesicles in preparation of a drug for treating schistosomiasis. The anti-infection immunity of a host is enhanced by adjusting intestinal flora balance (recovering diversity and composition) and improving immune response (adjusting macrophage, CD8 + T cell recruitment and Th1 / Th2 balance); meanwhile, the intestinal barrier function is improved, and pathogen invasion and inflammation are reduced; hepatic granuloma and hepatic fibrosis caused by schistosome infection are obviously relieved, and the liver function is improved; the key effect of the MIF gene in immunoregulation is disclosed, and a new direction is provided for schistosomiasis immunotherapy. Besides, the probiotics are high in treatment safety and free of obvious side effects, can be combined with chemotherapy to enhance the curative effect and reduce the side effects and drug resistance of chemical drugs, provides a lasting and comprehensive adjuvant therapy scheme for the schistosomiasis, and has important clinical application potential.
Owner:HUBEI UNIV OF MEDICINE

Genetic transformation method and application of muskmelon

The invention provides a genetic transformation method and application of muskmelon. The genetic transformation method comprises the following steps: carrying out co-culture treatment on an infected muskmelon explant and agrobacterium engineering bacteria in a sugar-free culture medium, and the sugar-free culture medium does not contain soluble sugar. By using the method, the co-culture time can be prolonged to 7-9 days, the infection efficiency of agrobacterium tumefaciens can be remarkably improved, the growth of the agrobacterium tumefaciens can be slowed down, agrobacterium tumefaciens pollution in the bud induction process is avoided, meanwhile, the immunoreaction of explants in the co-culture process is reduced, and the genetic transformation efficiency is further improved. Compared with an existing melon genetic transformation method in which co-culture time lasts for 4 days by adopting a sugar-containing culture medium, the genetic transformation method provided by the invention adopts a sugar-free culture medium and the co-culture time is prolonged to 8 days, so that the melon transgenosis efficiency can be improved by 14 times or more. The invention also provides an application of the genetic transformation method in preparation of a melon genetic transformation product.
Owner:HENAN AGRICULTURAL UNIVERSITY

Poxvirus single-chain fusion immunogen, immunogenic composition containing poxvirus single-chain fusion immunogen and application of poxvirus single-chain fusion immunogen

The invention relates to a single-chain fusion immunogen aiming at poxvirus (especially monkey poxvirus), an immunogenic composition containing the single-chain fusion immunogen and application of the single-chain fusion immunogen. The single-chain fusion immunogen comprises four immunogens which are connected in series and fused according to a specific sequence: monkey pox virus A35, M1, B6 and A29 proteins or antigenic fragments (or derivative peptide fragments thereof) of the proteins, and can excite immune response aiming at two infectious virus particles, namely intracellular mature virus particles (IMV) and extracellular membrane virus particles (EEV); therefore, the specific immune protection effect on the monkey pox virus is efficiently excited; in addition, the poxvirus vaccine disclosed by the invention also has good safety, quick responsiveness and capacity support, and has an excellent clinical application prospect.
Owner:PEKING UNIV +3

Applicable population screening method and application of glioma dry-like cell sensitized DC vaccine

The invention provides an applicable population screening method and application of a glioma dry-like cell sensitized DC vaccine, peripheral blood of a patient before and after inoculation of the glioma dry-like cell sensitized DC vaccine is obtained, mononuclear cells are extracted, CD8 + T cells are respectively separated from the mononuclear cells through a magnetic bead sorting method, and the CD8 + T cells are separated from the mononuclear cells. The method comprises the following steps: uniformly inoculating CD8 < + > T cells into an ELISPOT cell culture plate coated with an IFN-gamma antibody for culture, respectively setting an experimental group and a positive control group for culture, adding A2B5 < + > glioma cell lysis buffer into the experimental group and adding phytohemagglutinin into the positive control group, and carrying out ELISPOT staining on the cultured cells to obtain the secretion amount of FN-gamma before and after treatment of a patient. According to the secretion amount of the FN-gamma, patients with specific immune response to the glioma dry-like cell sensitization DC vaccine are screened, so that the glioma dry-like cell sensitization DC vaccine is conveniently popularized and applied, and the immune mechanism of the glioma dry-like cell sensitization DC vaccine is researched.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Preparation and application of dual-network hydrogel

The invention discloses preparation and application of dual-network hydrogel. The dual-network hydrogel comprises the following components: (Z1) a spinal cord acellular matrix network DSM formed by self-assembly of a spinal cord acellular matrix dSECM; and (Z2) a metal-polyphenol network MPN formed by coordination of metal ions and polyphenols; wherein the DSM and the MPN are cross-linked through hydrogen bonds to jointly form a double-network structure. DSM provides a microenvironment suitable for cell survival and growth for the dual-network hydrogel and induces stem cells to differentiate into neurons, and MPN provides the dual-network hydrogel with biological effects of inhibiting inflammation and accumulation of reactive oxygen species (ROS). The dual-network hydrogel has the advantages of the two components, the active component neurotrophic factor and the inhibitor loaded on the dual-network hydrogel can regulate and control immune response after SCI, improve neuroinflammation microenvironment and promote nerve repair, and a new strategy is provided for in-situ tissue repair of SCI.
Owner:EAST CHINA UNIV OF SCI & TECH

Bacillus velezensis, biological preparation and application of bacillus velezensis in plant disease prevention and growth promotion

The invention belongs to the technical field of agricultural biological control, and particularly relates to bacillus velezensis, a biological preparation and application of the bacillus velezensis in plant disease prevention and growth promotion. The bacillus velezensis is preserved in the China Center for Type Culture Collection, the preservation number of the bacillus velezensis is CCTCC NO: M 2025613, and the bacillus velezensis is classified and named as bacillus velezensis B54. Experiments show that the bacillus velezensis and the biological preparation thereof provided by the invention have broad-spectrum antagonistic activity, can effectively inhibit growth of pathogenic bacteria such as pythium spp and fusarium spp, induce plants to generate immune response, remarkably reduce the incidence rate of root rot and blight of the plants, can also generate plant growth stimulants, improve the development of plant root systems, improve the growth of the plant root systems and promote the growth of the plant root systems. The crop yield and quality are improved.
Owner:UNIV OF JINAN

Systems and methods for assessment of immune response and applications thereof

Systems and methods to assess immune receptor sequences can incorporate a language model to yield embedded representations and classification of immune status. Classification systems and method can include assessment of embedded immune receptor sequence representations that account for isotype or V(D)J gene segment selection. Systems and methods to assess immunity status can incorporate one or more classifiers to predict immune status.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Modulation and utilization of enantiomer-dependent immunological response to chiral nanoparticles

A method for modulation of an immune response utilizing chiral nanoparticles. The chiral nanoparticles can be synthesized from nanoparticle seed precursors using circularly polarized light. The chirality of the NPs can be measured using chirality measures such as the Osipov-Pickup-Dunmeur index, the Hausdorff chirality measure and by using circular dichroism spectra, g-factor spectra, and maximum g-factor for a specific wavelength. In-vivo tests in mice showed a 2.27-fold enhancement of immune cell maturation and 1584-fold enhancement of IgG production by L-nanoparticles versus D-nanoparticles. Both the in-vivo and in-vitro immune responses monotonically depend on the chirality, measured as g-factors, of the nanoparticles, indicating that nanoscale chirality of the nanoparticles can be used to regulate immune cell maturation. Finally, L-nanoparticles demonstrated 1258-fold higher efficiency as adjuvants for the H9N2 influenza virus versus D-nanoparticles or Alum, opening a path to utilization of nanoscale chirality in immunology.
Owner:THE RGT UNIV OF MICHIGAN +1